All articles tagged with #market debut
Originally Published 4 months ago — by Financial Times
A new cryptocurrency venture backed by Donald Trump's sons has experienced a significant surge in its market debut, highlighting growing interest and investment in digital assets associated with high-profile figures.
Originally Published 4 months ago — by Forbes
A digital token launched by World Liberty Financial, co-founded by Donald Trump and his family, debuted at a price significantly higher than its initial sale prices, reaching up to 15 times higher despite a recent decline, with the token's value influenced by trading activity and governance proposals. The venture is linked to Trump, but the family has yet to cash in from the market debut.
Originally Published 5 months ago — by Bloomberg.com
Crypto firm Bullish surged 84% in its debut after raising $1.1 billion in an IPO, with shares nearly doubling the initial price, marking a significant milestone in the crypto industry's move to public markets.
Originally Published 5 months ago — by Financial Times
Crypto exchange Bullish, backed by Peter Thiel, experienced a 170% surge during its market debut, highlighting strong investor interest in the platform.
Originally Published 5 months ago — by Yahoo Finance
Bullish, a crypto exchange operator, priced its IPO at $37 per share, valuing the company at over $5 billion, and aims to raise $1.1 billion, signaling strong investor interest and confidence in the growth of the digital assets industry.
Originally Published 1 year ago — by Yahoo Finance
Reddit's stock, RDDT, is trading slightly down on its second day after its IPO, following a 48% surge on its market debut. Investors are cautious due to the lack of a lockup period for share offerings, but the company is positioning itself as an AI play with potential for profitability. Skepticism remains about Reddit's path to sustainability and monetization despite the initial excitement in the market.
Originally Published 2 years ago — by Yahoo Finance
Arm Holdings' stock dipped below its IPO price as short sellers bet against the chip designer just a week after its Wall Street debut. The shares closed down 1.4% at $52.16, well below the $51 IPO price. This comes as doubts arise about the revival of IPOs after a long drought. Data and analytics company Ortex reported that about 14 million of Arm's shares were on loan, indicating a negative view from some market participants.
Originally Published 2 years ago — by Barron's
Instacart has priced its initial public offering (IPO) at $30 per share, which is at the upper end of its expected range. Early indications suggest that the stock could open at a higher price, making it one of the most anticipated IPOs of the year.
Originally Published 2 years ago — by Reuters
Jio Financial Services, a subsidiary of Reliance Industries, saw its shares fall by 5% on its market debut, valuing the company at $19 billion. Despite not yet establishing a presence in India's financial services sector, Jio Financial Services is expected to benefit from its access to data from Reliance's telecom, digital, and retail businesses. The company has already formed a joint venture with BlackRock to launch asset management services in India. Jio Financial Services aims to become a full-service financial services player.
Originally Published 2 years ago — by Markets Insider
VinFast, the Vietnamese electric carmaker, experienced a spectacular market debut in New York, reaching a value of $85 billion. However, the company has since seen a significant decline in its share value, losing almost half of its initial worth. This has also resulted in a substantial decrease in the net worth of VinFast's owner, Pham Nhat Vuong. Despite the setback, Vuong remains Vietnam's richest person. VinFast is yet to turn a profit and has faced criticism for its initial vehicle shipments to the US.
Originally Published 2 years ago — by Reuters
Biopharma company Acelyrin Inc. had a strong market debut on Nasdaq, with shares rising 28% and giving the company a market capitalization of $2.1 billion. The Los Angeles-based company raised $540 million by selling 30 million shares in an upsized offering. Acelyrin joins a spate of new listings recently that have fueled hopes of a recovery in IPO markets, including Johnson & Johnson's consumer health business Kenvue Inc.